Direct Capital

Leaders in Private Equity Direct Capital is a leading New Zealand private equity and venture capital firm, focused on supporting businesses in New Zealand and Australia. Direct Capital currently manages three specialist pools of capital: DIRECT CAPITAL PARTNERS III BIOPACIFICVENTURES TMT VENTURES Our philosophy Direct Capital is a pre-eminent provider of equity capital to Australasian businesses lacking ready access to the stock market, with a focus on increasing shareholder wealth in private companies, and assisting shareholders to release value. More On Our Philosophy > What we look for Direct Capital can invest between NZ$5m and NZ$30m (or more in conjunction with our investors) in successful New Zealand or Australian companies with Enterprise Values from NZ$20m to NZ$150m. We typically look to invest in companies which are characterised by: Profitable operating track records Strong professional management Long-term and sustainable competitive advantages in their markets	News Direct Capital Invests in Fishpond Direct Capital today announced that it has purchased a minority shareholding in online retailer Fishpond Limited. More > Toll Group acquires leading NZ freight forwarder Express Logistics Group Toll Group, the Asian region’s leading provider of integrated logistics, today announced the acquisition of Express Logistics Group (ELG), one of New Zealand’s largest freight forwarding companies. More > Making the best of it Deal flow has slowed in recession-hit New Zealand, but there is still plenly to keep GPs busy. More > New Zealand Pharmaceuticals acquires Dextra Laboratories Palmerston North, New Zealand, 3 September 2009—New Zealand Pharmaceuticals Ltd (“NZP”) has purchased Dextra Laboratories which was a UK subsidiary of the drug development company Summit plc. More >